Emerging therapeutic strategies to target APOE4 in Alzheimer's disease

FEBS J. 2026 Oct 5. doi: 10.1111/febs.70759. Online ahead of print.ABSTRACTThe apolipoprotein E ε4 (APOE4) allele is the strongest common genetic risk factor for late-onset Alzheimer's disease. However, its incomplete penetrance supports the view that it acts as a modifiable systems-level perturbati

W Wei I Jiang

Development and Validation of Two Analytical Methods Using High-Performance Liquid Chromatography and Atomic Absorption Spectroscopy for the Analysis of Tunisian Marketed Pharmaceutical Product-Based Insulin and Zinc: Application in Routine Stability Study

Biomed Chromatogr. 2026 Nov;40(11):e70585. doi: 10.1002/bmc.70585.ABSTRACTGiven the widespread reliance on insulin among diabetic patients, ensuring its stability is an essential task not only for preserving its therapeutic efficacy but also for safeguarding patient health and safety. In addition, i

M Majdi Ben Messaoud

A Clinical Insight into Von Hippel-Lindau Syndrome: Diagnostic Challenges

Prague Med Rep. 2026;127(3):211-214. doi: 10.14712/23362936.2026.27.ABSTRACTVon Hippel-Lindau (VHL) syndrome is a rare hereditary disorder characterised by the development of multiple benign and malignant tumours across various organs. Caused by mutations in the VHL tumour suppressor gene, it presen

G Giulia Andreia Curvelo Rosado